Patents by Inventor Eigenbrodt Erich

Eigenbrodt Erich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detecting the Presence of Pyruvate Kinase Isoenzyme in Feces
    Publication number: 20080113389
    Abstract: In order to selectively, qualitatively or/and quantitatively detect the pyruvate kinase isoenzyme of the tumor M2-PK type (tumor M2-PK) which serves as a tumor marker in human and animal feces to detect a malignant process in the gastrointestinal tract, tumor M2-PK is detected in a stool specimen by an immunoassay technique with the aid of at least one antibody which specifically binds tumor M2-PK and does not cross-react with any other pyruvate kinase isoenzyme. A test kit for diagnosing malignant tumor growth in the gastrointestinal tract and in particular in the intestines contains at least one receptor for tumor M2-PK which does not cross-react with any other pyruvate kinase isoenzyme and optionally contains additional reagents that are necessary for carrying out an immunoassay.
    Type: Application
    Filed: April 30, 2007
    Publication date: May 15, 2008
    Applicant: ScheBo Biotech AG
    Inventors: Eigenbrodt Erich, Scheefers-Borchel Ursula, Scheefers Hans
  • Detecting the presence of pyruvate kinase isoenzyme in feces
    Patent number: 7226751
    Abstract: In order to selectively, qualitatively or/and quantitatively detect the pyruvate kinase isoenzyme of the tumor M2-PK type (tumor M2-PK) which serves as a tumor marker in human and animal feces to detect a malignant process in the gastrointestinal tract, tumor M2-PK is detected in a stool specimen by an immunoassay technique with the aid of at least one antibody which specifically binds tumor M2-PK and does not cross-react with any other pyruvate kinase isoenzyme. A test kit for diagnosing malignant tumor growth in the gastrointestinal tract and in particular in the intestines contains at least one receptor for tumor M2-PK which does not cross-react with any other pyruvate kinase isoenzyme and optionally contains additional reagents that are necessary for carrying out an immunoassay.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: June 5, 2007
    Assignee: ScheBo Biotech AG
    Inventors: Eigenbrodt Erich, Scheefers-Borchel Ursula, Scheefers Hans
  • Detecting the presence of pyruvate kinase isoenzyme in feces
    Publication number: 20020102623
    Abstract: In order to selectively, qualitatively or/and quantitatively detect the pyruvate kinase isoenzyme of the tumor M2-PK type (tumor M2-PK) which serves as a tumor marker in human and animal feces to detect a malignant process in the gastrointestinal tract, tumor M2-PK is detected in a stool specimen by an immunoassay technique with the aid of at least one antibody which specifically binds tumor M2-PK and does not cross-react with any other pyruvate kinase isoenzyme. A test kit for diagnosing malignant tumor growth in the gastrointestinal tract and in particular in the intestines contains at least one receptor for tumor M2-PK which does not cross-react with any other pyruvate kinase isoenzyme and optionally contains additional reagents that are necessary for carrying out an immunoassay.
    Type: Application
    Filed: March 22, 2002
    Publication date: August 1, 2002
    Applicant: Erich EIGENBRODT
    Inventors: Eigenbrodt Erich, Scheefers-Borchel Ursula, Scheefers Hans